Windorfer A, Schipper R
Med Klin. 1979 Jul 13;74(28-29):1101-4.
In a pharmacokinetic study with healthy test persons we compared the forte-tablet form of cotrimoxazol produced by 4 different manufacturers. We were able to show that 3 of the tested products (2 well known standard products I and II as well as a new comparative product) achieved nearly equal high serum concentrations of sulfamethoxazole and trimethoprim. The serum concentrations of a fourth product, a generic product, were lower for sulfamethoxazole and trimethoprim. As the difference is of no statistical significance and the serum concentrations of the last product are within the therapeutic range this product is also qualified for therapeutic use. When the dose is given after a standard breakfast the serum values of sulfamethoxazole were slightly higher than if given on an empty stomach. However, the serum values of trimethoprim given on an empty stomach were higher.
在一项针对健康受试者的药代动力学研究中,我们比较了4家不同制造商生产的复方新诺明强力片剂。我们发现,3种受试产品(2种知名标准产品I和II以及1种新的对比产品)的磺胺甲恶唑和甲氧苄啶血清浓度几乎相等且很高。第四种产品(一种仿制药)的磺胺甲恶唑和甲氧苄啶血清浓度较低。由于差异无统计学意义且最后一种产品的血清浓度在治疗范围内,该产品也有治疗用途。当在标准早餐后给药时,磺胺甲恶唑的血清值略高于空腹给药时。然而,空腹给药时甲氧苄啶的血清值更高。